Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
79,74 USD | +0,62% | +0,33% | -3,20% |
Attività
- chirurgia generale e minimamente invasiva (28,8%): apparecchiature chirurgiche, sistemi di monitoraggio intraoperatorio, sistemi di ventilazione, eccetera;
- gestione del ritmo cardiaco (18,6%): pacemaker cardiaci impiantabili, defibrillatori impiantabili e defibrillatori automatici esterni, sonde per l'ablazione cardiaca, eccetera;
- malattie vascolari e cardiochirurgia (17,4%): stent coronarici, endoprotesi per l'aorta (17,5%).4%): stent coronarici, endoprotesi per patologie aortiche, sistemi di protezione distale, cateteri, protesi valvolari cardiache, apparecchiature per l'autotrasfusione, dispositivi per l'ablazione cardiaca, eccetera;
- disturbi della colonna vertebrale (14,1%): protesi spinali, protesi discali, sistemi di stimolazione cerebrale, tecnologie di innesto osseo e chirurgia spinale mini-invasiva, eccetera. Il Gruppo sviluppa anche attività di sistemi di navigazione chirurgica a guida di immagini mediche;
- malattie neurovascolari, dell'orecchio, del naso e della gola (ORL) e pelviche (8,2%);
- gestione del diabete (7,4%): sistemi di monitoraggio della glicemia interna ed esterna e pompe di insulina;
- disturbi neurologici (5,5%): prodotti per la neurostimolazione e la somministrazione di farmaci con pompa, strumenti diagnostici, ecc.
Le vendite nette sono distribuite geograficamente come segue: Irlanda (0,3%), Stati Uniti (50,9%) e altri (48,8%).
Numero di dipendenti: 95 000
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Cardiovascular
37,1
%
| 11 423 | 36,1 % | 11 573 | 37,1 % | +1,31% |
Neuroscience
28,7
%
| 8 784 | 27,7 % | 8 959 | 28,7 % | +1,99% |
Medical Surgical
27,0
%
| 9 141 | 28,8 % | 8 433 | 27,0 % | -7,75% |
Diabetes
7,2
%
| 2 338 | 7,4 % | 2 262 | 7,2 % | -3,25% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
52,4
%
| 16 134 | 50,9 % | 16 373 | 52,4 % | +1,48% |
Non-United States Developed Markets
29,8
%
| 10 025 | 31,6 % | 9 310 | 29,8 % | -7,13% |
Emerging Markets
17,4
%
| 5 426 | 17,1 % | 5 446 | 17,4 % | +0,37% |
Ireland
0,3
%
| 101 | 0,3 % | 98 | 0,3 % | -2,97% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 26/01/15 |
Karen Parkhill
DFI | Director of Finance/CFO | 58 | 01/06/16 |
Gregory Smith
COO | Chief Operating Officer | 60 | 01/04/21 |
Laura Mauri
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/18 |
Chief Tech/Sci/R&D Officer | 63 | 01/06/23 | |
Investor Relations Contact | - | 01/06/99 | |
Sean Salmon
PRN | Corporate Officer/Principal | - | 01/01/04 |
Noel Colon
PRN | Corporate Officer/Principal | - | 01/03/08 |
Yushao Gu
PRN | Corporate Officer/Principal | 55 | 01/01/15 |
Raman Venkatesh
PRN | Corporate Officer/Principal | - | 21/02 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Scott Donnelly
BRD | Director/Board Member | 62 | 01/01/13 |
Kendall Powell
BRD | Director/Board Member | 70 | 01/01/07 |
Randall Hogan
BRD | Director/Board Member | 68 | 01/01/15 |
Denise O'Leary
BRD | Director/Board Member | 66 | 01/01/00 |
Craig Arnold
BRD | Director/Board Member | 64 | 26/01/15 |
Kevin Lofton
BRD | Director/Board Member | 69 | 15/09/20 |
Lidia Fonseca
BRD | Director/Board Member | 55 | 27/06/22 |
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 26/01/15 |
Elizabeth Nabel
BRD | Director/Board Member | 72 | 01/01/14 |
Gregory Lewis
BRD | Director/Board Member | 53 | 26/06/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 1 327 822 539 | 1 325 378 582 ( 99,82 %) | 0 | 99,82 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
5 868 916 | 16.42% | 30 929 187 $ |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. |
Medical Specialties
|
Covidien Group SARL
Covidien Group SARL Medical SpecialtiesHealth Technology Part of Medtronic Plc, Covidien Group SARL is a Luxembourger company that manufactures medical devices, diagnostic imaging agents, and pharmaceuticals. The private company is based in Luxembourg, Luxembourg. |
Medical Specialties
|
Covidien LP
Covidien LP Medical SpecialtiesHealth Technology Covidien LP manufactures and distributes medical devices. Its products include disposable medical supplies, monitoring equipment, innovative wound closure products, advanced surgical devices, medical instruments and bulk analgesic pharmaceuticals. The company is headquartered in Mansfield, MA. |
Medical Specialties
|
Medtronic International Technology, Inc.
| |
Arterial Vascular Engineering Canada Co.
| |
Arterial Vascular Engineering UK Ltd.
Arterial Vascular Engineering UK Ltd. Financial ConglomeratesFinance Part of Medtronic Plc, Arterial Vascular Engineering UK Ltd. provides investment services. The private company is based in London, UK. Founded in 1995. |
Financial Conglomerates
|
Medtronic AB
| |
Medtronic Korea Co. Ltd.
Medtronic Korea Co. Ltd. Hospital/Nursing ManagementHealth Services Medtronic Korea Co., Ltd. engages in the manufacture and sale of medical products. It operates through the follow businesses: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabettes. The company was founded on June 21. 2000 and is headquartered in Seoul, South Korea. |
Hospital/Nursing Management
|
Medtronic Bakken Research Center BV
Medtronic Bakken Research Center BV Medical SpecialtiesHealth Technology Part of Medtronic Plc, Medtronic Bakken Research Center BV is a Dutch company that specializes in providing innovative products, services, and solutions to help spine surgeons overcome their biggest challenges. The private company is based in Maastricht, Netherlands. The company also offers products for neurological procedures, surgery, neurostimulation, and drug infusion systems for chronic pain and severe spasticity. Founded in 1987, the company offers care management services that provide remote patient monitoring programs to improve patient health and deliver economic benefits to the healthcare system. |
Medical Specialties
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-3,20% | 106 Mrd | |
-2,31% | 187 Mrd | |
-5,04% | 66,9 Mrd | |
+0,20% | 49,45 Mrd | |
+17,29% | 48 Mrd | |
+4,06% | 40,84 Mrd | |
+2,07% | 26,48 Mrd | |
+2,36% | 26,25 Mrd | |
+12,96% | 24,62 Mrd | |
-1,93% | 24,52 Mrd |
- Borsa valori
- Azioni
- Azione MDT
- Società Medtronic plc